Literature DB >> 11277075

Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways.

G M Morriss-Kay1, S Iseki, D Johnson.   

Abstract

Activating mutations of genes encoding the transmembrane tyrosine kinase receptors fibroblast growth factor receptors (FGFRs)1-3, and haploinsufficiency of the transcription factor TWIST, cause human craniosynostosis syndromes that typically involve the coronal suture. We have investigated the functional roles of these genes in development of the coronal suture in mouse fetuses, and tested the effects of increasing FGFR signalling by applying exogenous FGF2 to the suture. The results indicate that the proliferation-differentiation balance in normal sutural development involves a gradient of extracellular FGF from the region of differentiation, in which Fgfr1 is expressed, to the sutural mesenchyme, in which low levels of FGF are associated with Fgfr2 expression in osteogenic stem cells. Experimental increase of sutural FGF levels leads to down-regulation of Fgfr2, up-regulation of Fgfr1, up-regulation of the osteogenic differentiation gene Osteopontin, and cessation of proliferation. Twist is expressed in the midsutural mesenchyme and is partially co-expressed with Fgfr2, consistent with the possibility that it is involved in maintaining proliferation through regulating transcription of Fgfr2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277075     DOI: 10.1002/0470846658.ch8

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  3 in total

1.  Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.

Authors:  Andrew P Baraniak; Jing R Chen; Mariano A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

2.  Phenotypic integration of neurocranium and brain.

Authors:  Joan T Richtsmeier; Kristina Aldridge; Valerie B DeLeon; Jayesh Panchal; Alex A Kane; Jeffrey L Marsh; Peng Yan; Theodore M Cole
Journal:  J Exp Zool B Mol Dev Evol       Date:  2006-07-15       Impact factor: 2.656

3.  Fibroblast growth factor (FGF) signaling in development and skeletal diseases.

Authors:  Chad M Teven; Evan M Farina; Jane Rivas; Russell R Reid
Journal:  Genes Dis       Date:  2014-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.